1047637-17-1 Usage
Chemical structure
A chemical compound with a triazole ring structure and three n-butylstannyl groups attached to the carbon atom.
Common use
Used in organic synthesis and as a reagent for the preparation of various functionalized triazoles.
Intermediate
The presence of the tri-n-butylstannyl groups makes it a useful intermediate in the preparation of other organic compounds and materials.
Application in medicinal chemistry
Utilized in the design and synthesis of potential pharmaceuticals.
Application in agrochemical research
Used in the design and synthesis of potential pesticides.
Unique structure and reactivity
Its unique structure and reactivity have led to its investigation for potential applications in materials science and nanotechnology.
Check Digit Verification of cas no
The CAS Registry Mumber 1047637-17-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,4,7,6,3 and 7 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1047637-17:
(9*1)+(8*0)+(7*4)+(6*7)+(5*6)+(4*3)+(3*7)+(2*1)+(1*7)=151
151 % 10 = 1
So 1047637-17-1 is a valid CAS Registry Number.
1047637-17-1Relevant articles and documents
ATR INHIBITORS AND USES THEREOF
-
Paragraph 00350, (2022/02/15)
The present disclosure relates to novel compounds useful as inhibitors of ATR kinase, as well as pharmaceutical compositions comprising these compounds and methods of treatment by administration of these compounds or the pharmaceutical compositions.
EZH2 Inhibitors
-
Paragraph 0448; 0450; 0451, (2018/11/02)
The present invention relates to compounds that inhibit EZH2 activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.
